Overview

PGD2 Formation in Vascular Injury

Status:
Terminated
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
To investigate the biosynthesis of PGD2 during percutaneous transluminal coronary angioplasty (PTCA) procedure.
Details
Lead Sponsor:
University of Pennsylvania
Treatments:
Aspirin